Discovery - University of Dundee - Online Publications

Library & Learning Centre

Detailed protocol for the lifestyle intervention in the BeWEL randomised controlled trial of weight loss in adults who have had a colorectal adenoma

Standard

Detailed protocol for the lifestyle intervention in the BeWEL randomised controlled trial of weight loss in adults who have had a colorectal adenoma. / Caswell, Stephen; Craigie, Angela M; Wardle, Jane; Stead, Martine; Anderson, Annie.

In: BMJ Open, Vol. 2, No. 3, e001276, 2012.

Research output: Contribution to journalArticle

Harvard

Caswell, S, Craigie, AM, Wardle, J, Stead, M & Anderson, A 2012, 'Detailed protocol for the lifestyle intervention in the BeWEL randomised controlled trial of weight loss in adults who have had a colorectal adenoma' BMJ Open, vol 2, no. 3, e001276.

APA

Caswell, S., Craigie, A. M., Wardle, J., Stead, M., & Anderson, A. (2012). Detailed protocol for the lifestyle intervention in the BeWEL randomised controlled trial of weight loss in adults who have had a colorectal adenoma. BMJ Open, 2(3), [e001276]doi: 10.1136/bmjopen-2012-001276

Vancouver

Caswell S, Craigie AM, Wardle J, Stead M, Anderson A. Detailed protocol for the lifestyle intervention in the BeWEL randomised controlled trial of weight loss in adults who have had a colorectal adenoma. BMJ Open. 2012;2(3). e001276.

Author

Caswell, Stephen; Craigie, Angela M; Wardle, Jane; Stead, Martine; Anderson, Annie / Detailed protocol for the lifestyle intervention in the BeWEL randomised controlled trial of weight loss in adults who have had a colorectal adenoma.

In: BMJ Open, Vol. 2, No. 3, e001276, 2012.

Research output: Contribution to journalArticle

Bibtex - Download

@article{c2e27fd80fe144b68337ed596c14de7f,
title = "Detailed protocol for the lifestyle intervention in the BeWEL randomised controlled trial of weight loss in adults who have had a colorectal adenoma",
author = "Stephen Caswell and Craigie, {Angela M} and Jane Wardle and Martine Stead and Annie Anderson",
year = "2012",
volume = "2",
number = "3",
journal = "BMJ Open",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Detailed protocol for the lifestyle intervention in the BeWEL randomised controlled trial of weight loss in adults who have had a colorectal adenoma

A1 - Caswell,Stephen

A1 - Craigie,Angela M

A1 - Wardle,Jane

A1 - Stead,Martine

A1 - Anderson,Annie

AU - Caswell,Stephen

AU - Craigie,Angela M

AU - Wardle,Jane

AU - Stead,Martine

AU - Anderson,Annie

PY - 2012

Y1 - 2012

N2 - INTRODUCTION: The BeWEL study is aimed at assessing the impact of a personalised lifestyle programme on body weight in people at risk of developing colorectal adenomas. The study is a two-arm multicentre randomised controlled trial comparing the BeWEL lifestyle programme against usual care. Over 12 months, 316 people who have had a colorectal adenoma removed through the national screening programme will be randomised to provide 80% power to detect a weight loss (primary outcome) of 7% over 12 months. METHODS: The 12-month intervention will be delivered by lifestyle counsellors via three face-to-face visits followed by nine monthly telephone support calls. Consultant endorsement for the study will be stressed. An individualised caloric prescription based on estimates for weight maintenance -600 kcal will be calculated. Motivational interviewing techniques will be used to identify personal motivations for weight change and ways to improve perceived self-efficacy. The programme will utilise personalised diet and physical activity data from baseline measures to set behavioural goals. A range of behavioural strategies will be employed to support lifestyle change including goal setting, identifying specific implementation intentions, self-monitoring and feedback. Emphasis will be placed on self-monitoring body weight, and weighing scales will be provided. Programme acceptability will be explored postintervention with indepth interviews. Compliance and impact will be assessed by baseline and follow-up measures of diet by self-report, activity by accelerometry and anthropometry. ETHICS AND DISSEMINATION: Ethical approval has been obtained from the Tayside Committee on Medical Research Ethics. Dissemination of results will focus on publications in peer-reviewed journals, presentations at national/international cancer meetings and NHS groups. In addition, the work will be communicated to the public through forums such at The Scottish Cancer Prevention Network (http://www.cancerpreventionscotland.co.uk/). The trial is registered with Current Controlled Trials (International Standard Randomised Controlled Trials No: ISRCTN53033856).

AB - INTRODUCTION: The BeWEL study is aimed at assessing the impact of a personalised lifestyle programme on body weight in people at risk of developing colorectal adenomas. The study is a two-arm multicentre randomised controlled trial comparing the BeWEL lifestyle programme against usual care. Over 12 months, 316 people who have had a colorectal adenoma removed through the national screening programme will be randomised to provide 80% power to detect a weight loss (primary outcome) of 7% over 12 months. METHODS: The 12-month intervention will be delivered by lifestyle counsellors via three face-to-face visits followed by nine monthly telephone support calls. Consultant endorsement for the study will be stressed. An individualised caloric prescription based on estimates for weight maintenance -600 kcal will be calculated. Motivational interviewing techniques will be used to identify personal motivations for weight change and ways to improve perceived self-efficacy. The programme will utilise personalised diet and physical activity data from baseline measures to set behavioural goals. A range of behavioural strategies will be employed to support lifestyle change including goal setting, identifying specific implementation intentions, self-monitoring and feedback. Emphasis will be placed on self-monitoring body weight, and weighing scales will be provided. Programme acceptability will be explored postintervention with indepth interviews. Compliance and impact will be assessed by baseline and follow-up measures of diet by self-report, activity by accelerometry and anthropometry. ETHICS AND DISSEMINATION: Ethical approval has been obtained from the Tayside Committee on Medical Research Ethics. Dissemination of results will focus on publications in peer-reviewed journals, presentations at national/international cancer meetings and NHS groups. In addition, the work will be communicated to the public through forums such at The Scottish Cancer Prevention Network (http://www.cancerpreventionscotland.co.uk/). The trial is registered with Current Controlled Trials (International Standard Randomised Controlled Trials No: ISRCTN53033856).

U2 - 10.1136/bmjopen-2012-001276

DO - 10.1136/bmjopen-2012-001276

M1 - Article

JO - BMJ Open

JF - BMJ Open

IS - 3

VL - 2

ER -

Documents

Library & Learning Centre

Contact | Accessibility | Policy